Raloxifene reduces risk of invasive oestrogen-receptor positive breast cancer
Tuesday, June 10, 2008 - 20:49
in Health & Medicine
Women who took raloxifene were less likely to develop invasive oestrogen-receptor (ER) positive breast cancer compared with women who did not, according to data from a randomised controlled trial published online 10 June in the Journal of the National Cancer Institute...
Read the whole article on Science Centric
More from Science Centric
Related
- Raloxifene reduces risk of invasive estrogen-receptor positive breast cancerTue, 10 Jun 2008, 21:49:51 EDT
- Anti-estrogen drug therapy reduces risk of invasive breast cancer in older womenTue, 10 Jun 2008, 21:49:44 EDT
- JNCI news brief: Breast cancer hormone receptor status and risk of a second primary tumorThu, 9 Jul 2009, 16:32:03 EDT
- Daily aspirin may reduce risk of common type of breast cancerWed, 30 Apr 2008, 14:57:29 EDT
- Tamoxifen chemoprevention associated with earlier diagnosis of ER-negative breast cancerTue, 7 Oct 2008, 16:36:25 EDT